PD-1+CD8+T cells as immunological biomarkers for the safe discontinuation of anti-viral therapy in chronic hepatitis B

被引：2
|
作者：
Le Bert, N. [1 ]
Rivino, L. [2 ]
Gill, U. S. [3 ]
Cheng, Y. [4 ]
Kunasegaran, K. [2 ]
Tan, D. Z. [1 ]
Becht, E. [4 ]
Hansi, N. K. [3 ]
Foster, G. R. [3 ]
Newell, E. W. [4 ]
Kennedy, P. T. F. [3 ]
Bertoletti, A. [1 ,2 ,4 ]
机构：
[1] ASTAR, Singapore Inst Clin Sci, Infect & Immun Program, Singapore, Singapore
[2] Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore
[3] QMUL, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol,Hepatol, London, England
[4] ASTAR, Singapore Immunol Network, Singapore, Singapore
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31847-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-152
引用
收藏
页码：S687 / S687
页数：1
相关论文
共 50 条
  • [31] Hepatitis B virus genotype variability and its influence on anti-viral therapy in HBeAg positive chronic hepatitis B in India.
    Thakur, V
    Maerten, G
    Guptan, RC
    Kazim, SN
    Sarin, SK
    HEPATOLOGY, 1998, 28 (04) : 216A - 216A
  • [32] Defective T helper 1 response by hepatocyte-stimulated CDA T cells impairs anti-viral CD8 response and viral clearance
    Herkel, Johannes
    Wiegard, Christiane
    Wolint, Petra
    Frenzel, Christian
    Schmitt, Edgar
    Oxenius, Annette
    Lohse, Ansgar W.
    HEPATOLOGY, 2007, 46 (04) : 240A - 240A
  • [33] MicroRNA-155 regulates T-bet expression in anti-viral CD8+T cells
    Hope, Jennifer L.
    Stairiker, Christopher
    Spantidea, Panagiota
    Gracias, Donald Tom
    Carey, Alison J.
    van Meurs, Marjan
    Brouwers-Haspels, Inge
    Fike, Adam J.
    Rijsbergen, Laurine
    Mueller, Yvonne M.
    Fraietta, Joseph A.
    Klop, Roos
    Erkeland, Stefan
    Katsikis, Peter D.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [34] The hidden strength of CD8+ T cells in chronic hepatitis B
    Andreata, Francesco
    Iannacone, Matteo
    NATURE IMMUNOLOGY, 2024, : 1515 - 1516
  • [35] Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides
    Müller, H
    Mayer, G
    Behnke, B
    Heimüller, E
    Hamscher, G
    Immler, D
    Siethoff, C
    Meyer, HE
    Schreiber, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 117 (01): : 76 - 83
  • [36] Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Tian, Yongjun
    Ou, Jing-hsiung James
    HEPATOLOGY, 2019, 69 (03) : 1342 - 1344
  • [37] Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct-acting anti-viral therapy
    Huang, R.
    Yan, X.
    Xia, J.
    Wang, J.
    Wu, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1558 - 1558
  • [38] Unravelling the fate of functional PD1+ T cells in chronic viral hepatitis
    Barnes, Eleanor
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 573 - 576
  • [39] The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients
    Ruyu Liu
    Yanhui Chen
    Jiang Guo
    Minghui Li
    Yao Lu
    Lu Zhang
    Ge Shen
    Shuling Wu
    Min Chang
    Leiping Hu
    Hongxiao Hao
    Henghui Zhang
    Yao Xie
    BMC Infectious Diseases, 20
  • [40] The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients
    Liu, Ruyu
    Chen, Yanhui
    Guo, Jiang
    Li, Minghui
    Lu, Yao
    Zhang, Lu
    Shen, Ge
    Wu, Shuling
    Chang, Min
    Hu, Leiping
    Hao, Hongxiao
    Zhang, Henghui
    Xie, Yao
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
12345